FDA approves first gene therapies to treat sickle cell disease
Published
ViewTwo gene therapies that the Food and Drug Administration describes as "milestones" were approved Friday for treatment of sickle cell disease.
The Centers for Disease Control and Prevention says 100,000 Americans are living with sickle cell disease, which disproportionately affects Black and Hispanic individuals.
"The...